Koshinski Asset Management, Inc. Gilead Sciences, Inc. Transaction History

Koshinski Asset Management, Inc.

$1.13 Billion
Q3 2024

A detailed history of Koshinski Asset Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Koshinski Asset Management, Inc. holds 3,615 shares of GILD stock, worth $318,409. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,615

Previous 3,356 7.72%

Holding current value

$318,409

Previous $230,000 31.74%

% of portfolio

0.03%

Previous 0.02%

39 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$66.59 - $83.99 $17,246 - $21,753	259 Added 7.72%	3,615 $303,000
Q2 2024 Jul 12, 2024	BUY	$63.15 - $72.88 $25,133 - $29,006	398 Added 13.46%	3,356 $230,000
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $211,733 - $258,203	2,958 New	2,958 $216,000
Q3 2023 Oct 18, 2023	BUY	$73.94 - $80.67 $10,721 - $11,697	145 Added 5.12%	2,975 $222,000
Q2 2023 Jul 28, 2023	SELL	$76.01 - $86.7 $51,458 - $58,695	-677 Reduced 19.3%	2,830 $218,000
Q1 2023 Apr 12, 2023	SELL	$77.31 - $88.08 $19,636 - $22,372	-254 Reduced 6.75%	3,507 $290,000
Q4 2022 Jan 24, 2023	SELL	$62.32 - $89.47 $75,157 - $107,900	-1,206 Reduced 24.28%	3,761 $0
Q3 2022 Oct 18, 2022	BUY	$59.54 - $68.01 $47,870 - $54,680	804 Added 19.31%	4,967 $306,000
Q2 2022 Jul 12, 2022	SELL	$57.72 - $65.01 $37,518 - $42,256	-650 Reduced 13.51%	4,163 $257,000
Q1 2022 Apr 20, 2022	BUY	$57.92 - $72.58 $57 - $72	1 Added 0.02%	4,813 $286 Million
Q4 2021 Jan 14, 2022	SELL	$64.88 - $73.64 $4,801 - $5,449	-74 Reduced 1.51%	4,812 $349 Million
Q3 2021 Oct 12, 2021	BUY	$67.69 - $73.03 $27,279 - $29,431	403 Added 8.99%	4,886 $341,000
Q2 2021 Jul 26, 2021	SELL	$63.47 - $69.35 $100,663 - $109,989	-1,586 Reduced 26.13%	4,483 $309,000
Q1 2021 May 06, 2021	SELL	$60.0 - $68.46 $182,460 - $208,186	-3,041 Reduced 33.38%	6,069 $392,000
Q4 2020 Mar 30, 2021	BUY	$56.65 - $64.55 $83,502 - $95,146	1,474 Added 19.3%	9,110 $530,000
Q4 2020 Feb 05, 2021	BUY	$56.65 - $64.55 $432,579 - $492,903	7,636 New	7,636 $530,000
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $263,592 - $300,351	-4,653 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $77,438 - $97,365	-1,247 Reduced 21.14%	4,653 $300,000
Q2 2020 Jul 29, 2020	BUY	$72.34 - $84.0 $69,229 - $80,388	957 Added 19.36%	5,900 $454,000
Q1 2020 Apr 30, 2020	BUY	$62.63 - $80.22 $309,580 - $396,527	4,943 New	4,943 $370,000
Q2 2019 Jul 18, 2019	SELL	$61.87 - $69.38 $210,914 - $236,516	-3,409 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $179,711 - $201,323	-2,874 Reduced 45.74%	3,409 $222,000
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $261,653 - $341,438	-4,322 Reduced 40.75%	6,283 $393,000
Q3 2018 Nov 15, 2018	BUY	$71.28 - $78.92 $341,645 - $378,263	4,793 Added 82.47%	10,605 $819,000
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $137,934 - $160,895	2,126 Added 57.68%	5,812 $412,000
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $173,748 - $202,671	-2,678 Reduced 42.08%	3,686 $963,000
Q1 2018 Apr 09, 2018	SELL	$72.84 - $88.8 $117,199 - $142,879	-1,609 Reduced 20.18%	6,364 $480,000
Q4 2017 Jan 17, 2018	SELL	$71.15 - $83.52 $19,922 - $23,385	-280 Reduced 3.39%	7,973 $571,000
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $31,728 - $37,606	440 Added 5.63%	8,253 $0
Q2 2017 Jan 17, 2018	BUY	N/A	4,033 Added 106.69%	7,813 $553,000
Q1 2017 Jan 17, 2018	SELL	N/A	-1,435 Reduced 27.52%	3,780 $257,000
Q4 2016 Jan 17, 2018	SELL	N/A	-3,760 Reduced 41.89%	5,215 $416,000
Q3 2016 Jan 17, 2018	BUY	N/A	345 Added 4.0%	8,975 $710,000
Q2 2016 Jan 17, 2018	BUY	N/A	1,462 Added 20.4%	8,630 $720,000
Q1 2016 Jan 17, 2018	BUY	N/A	1,392 Added 24.1%	7,168 $683,000
Q4 2015 Jan 17, 2018	SELL	N/A	-214 Reduced 3.57%	5,776 $584,000
Q3 2015 Jan 17, 2018	BUY	N/A	1,158 Added 23.97%	5,990 $701,000
Q2 2015 Jan 17, 2018	BUY	N/A	2,662 Added 122.67%	4,832 $566,000
Q4 2014 Jan 17, 2018	BUY	N/A	2,170	2,170 $205,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Koshinski Asset Management, Inc. with notifications on news.

Account

Koshinski Asset Management, Inc. Gilead Sciences, Inc. Transaction History